Dr Reddy's gets 8 observations from USFDA for its Duvvada facility
21st Aug 2019

US Food and Drug Administration (USFDA) has issued eight observations to Dr Reddy's Laboratories after the inspection of Formulations Manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam in Andhra Pradesh. The company has been issued Form 483 with 8 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.